Series B funding round for Tempest Therapeutics raising $70M in March 2018
Series B funding round for Tempest Therapeutics raising $70M in March 2018
| Investor | Firm Type | Partner |
|---|
| Private | — | |
Quan CapitalLEAD | Venture Capital | — |
Versant VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Anthony Philippakis |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$70M
Top Valuation
-
Tempest Therapeutics raised $70M in a Series B round.
The round was announced on 03/01/18.
The round was led by Versant Ventures, Robert Weisskoff, Stella Xu.